We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

162 hedge funds and large institutions have $465M invested in Anika Therapeutics in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 67 increasing their positions, 49 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

37% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 49

11% more capital invested

Capital invested by funds: $417M → $465M (+$47.4M)

6% more funds holding

Funds holding: 153 → 162 (+9)

1% more call options, than puts

Call options by funds: $4.03M | Put options by funds: $4M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
162
Holders Change
+9
Holders Change %
+5.88%
% of All Funds
4.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
67
Reduced
49
Closed
15
Calls
$4.03M
Puts
$4M
Net Calls
+$28K
Net Calls Change
+$1.87M

Top Buyers

1
TSW
Thompson Siegel & Walmsley
Virginia
+$11.7M
2
GAM
Gotham Asset Management
New York
+$10.5M
3
TC
TFS Capital
Pennsylvania
+$4.14M
4
BA
BlackRock Advisors
Delaware
+$3.87M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.37M

Top Sellers

1
SFM
Systematic Financial Management
New Jersey
-$26.4M
2
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$7.58M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6.49M
4
PCM
Perritt Capital Management
Illinois
-$6.45M
5
OAM
Oxford Asset Management
United Kingdom
-$4.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSERS
126
Louisiana State Employees Retirement System
Louisiana
$255K +$13.3K +300 +6%
JG
127
Jefferies Group
New York
$254K +$244K +5,484 New
CEP
128
Chicago Equity Partners
Illinois
$249K -$53.4K -1,200 -18%
Capital Fund Management (CFM)
129
Capital Fund Management (CFM)
France
$245K +$236K +5,298 New
QI
130
Quotient Investors
New York
$241K – – –
EMG
131
Ellington Management Group
Connecticut
$241K +$231K +5,200 New
LG
132
Laidlaw Group
New York
$234K +$224K +5,040 New
PGCM
133
Prescott Group Capital Management
Oklahoma
$232K – – –
UBS AM
134
UBS AM
Illinois
$222K +$213K +4,800 New
Citigroup
135
Citigroup
New York
$197K +$12.4K +279 +7%
KBC Group
136
KBC Group
Belgium
$178K – – –
Bank of Montreal
137
Bank of Montreal
Ontario, Canada
$153K +$21.4K +482 +17%
PCM
138
Prelude Capital Management
New York
$128K +$35.6K +800 +41%
BJ
139
BlackRock Japan
Japan
$124K +$119K +2,681 New
Group One Trading
140
Group One Trading
Illinois
$111K -$398K -8,957 -79%
TAM
141
Tocqueville Asset Management
New York
$98K +$10.7K +241 +13%
PI
142
PineBridge Investments
New York
$86K -$39.8K -895 -32%
EARNEST Partners
143
EARNEST Partners
Georgia
$69K – – –
MSA
144
Mason Street Advisors
Wisconsin
$69K +$4.8K +108 +8%
RA
145
Royce & Associates
New York
$60K – – –
MSFP
146
Mark Sheptoff Financial Planning
Connecticut
$60K +$44.5K +1,000 +333%
OA
147
OFI Advisors
Pennsylvania
$52K +$9.92K +223 +25%
Creative Planning
148
Creative Planning
Kansas
$46K – – –
US Bancorp
149
US Bancorp
Minnesota
$43K +$40.9K +920 New
RIA
150
Regal Investment Advisors
Michigan
$31K +$15.4K +346 +106%
4 5
6
7 8

ANIK Hedge Fund Activity: Q2 2014 in Review

162 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q2 2014, worth a combined $465M — up 11% from $417M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ANIK positions and 15 closed out — a net gain of 9 holders — while 67 added to existing stakes and 49 trimmed.

The largest buyer was Thompson Siegel & Walmsley, adding an estimated $11.7M. The largest seller was Systematic Financial Management, cutting an estimated $26.4M.

  • 162 institutional investors held Anika Therapeutics (ANIK) as of Q2 2014, up from 153 in Q1 2014.
  • Funds reported $465M of Anika Therapeutics stock for Q2 2014, up 11% quarter-over-quarter.
  • 24 funds opened new Anika Therapeutics positions in Q2 2014 and 15 closed out, a net change of +9 holders.
  • The largest Anika Therapeutics buyer in Q2 2014 was Thompson Siegel & Walmsley, an estimated $11.7M added.
  • The largest Anika Therapeutics seller in Q2 2014 was Systematic Financial Management, an estimated $26.4M sold.

Based on aggregated 13F filings for Q2 2014.